Literature DB >> 20702070

The role of hippocampus dysfunction in deficient memory encoding and positive symptoms in schizophrenia.

Kathrin Zierhut1, Bernhard Bogerts, Björn Schott, Daniela Fenker, Martin Walter, Dominik Albrecht, Johann Steiner, Hartmut Schütze, Georg Northoff, Emrah Düzel, Kolja Schiltz.   

Abstract

BACKGROUND: Declarative memory disturbances, known to substantially contribute to cognitive impairment in schizophrenia, have previously been attributed to prefrontal as well as hippocampal dysfunction. AIMS: To characterize the role of prefrontal and mesolimbic/hippocampal dysfunction during memory encoding in schizophrenia.
METHOD: Neuronal activation in schizophrenia patients and controls was assessed using functional magnetic resonance imaging (fMRI) during encoding of words in a deep (semantic judgement) and shallow (case judgment) task. A free recall (no delay) and a recognition task (24h delay) were performed.
RESULTS: Free recall, but not recognition performance was reduced in patients. Reduced performance was correlated with positive symptoms which in turn were related to increased left hippocampal activity during successful encoding. Furthermore, schizophrenia patients displayed a hippocampal hyperactivity during deep encoding irrespective of encoding success along with a reduced anterior cingulate cortex (ACC) and dorsomedial prefrontal cortex (DMPFC) activity in successful encoding but an intact left inferior frontal cortex (LIFC) activity.
CONCLUSIONS: This study provides the first evidence directly linking positive symptoms and memory deficits to dysfunctional hippocampal hyperactivity. It thereby underscores the pivotal pathophysiological role of a hyperdopaminergic mesolimbic state in schizophrenia.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20702070     DOI: 10.1016/j.pscychresns.2010.03.007

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  29 in total

1.  Treatment with levetiracetam improves cognition in a ketamine rat model of schizophrenia.

Authors:  Ming Teng Koh; Yi Shao; Sharon Rosenzweig-Lipson; Michela Gallagher
Journal:  Schizophr Res       Date:  2017-06-17       Impact factor: 4.939

Review 2.  Epigenetic mechanisms in alcohol- and adversity-induced developmental origins of neurobehavioral functioning.

Authors:  K E Boschen; S M Keller; T L Roth; A Y Klintsova
Journal:  Neurotoxicol Teratol       Date:  2018-01-02       Impact factor: 3.763

3.  Impaired Right Temporoparietal Junction-Hippocampus Connectivity in Schizophrenia and Its Relevance for Generating Representations of Other Minds.

Authors:  Florian Bitsch; Philipp Berger; Arne Nagels; Irina Falkenberg; Benjamin Straube
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 9.306

4.  Behavioral changes and dopaminergic dysregulation in mice lacking the nuclear receptor Rev-erbα.

Authors:  Jennifer Jager; W Timothy O'Brien; Jessica Manlove; Elizabeth N Krizman; Bin Fang; Zachary Gerhart-Hines; Michael B Robinson; Peter S Klein; Mitchell A Lazar
Journal:  Mol Endocrinol       Date:  2014-02-19

5.  Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors.

Authors:  Graham M Pitcher; Lorraine V Kalia; David Ng; Nathalie M Goodfellow; Kathleen T Yee; Evelyn K Lambe; Michael W Salter
Journal:  Nat Med       Date:  2011-03-27       Impact factor: 53.440

6.  Depressed mood in individuals with schizophrenia: A comparison of retrospective and real-time measures.

Authors:  Lisa H Blum; Julia Vakhrusheva; Alice Saperstein; Samira Khan; Rachel W Chang; Marie C Hansen; Vance Zemon; David Kimhy
Journal:  Psychiatry Res       Date:  2015-03-16       Impact factor: 3.222

7.  Hippocampal shape abnormalities of patients with childhood-onset schizophrenia and their unaffected siblings.

Authors:  Sarah L M Johnson; Lei Wang; Kathryn I Alpert; Deanna Greenstein; Liv Clasen; Francois Lalonde; Rachel Miller; Judith Rapoport; Nitin Gogtay
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-04-03       Impact factor: 8.829

8.  Schizophrenia comorbid with panic disorder: evidence for distinct cognitive profiles.

Authors:  Erica Kirsten Rapp; Mandi Lynn White-Ajmani; Daniel Antonius; Raymond Richard Goetz; Jill Martine Harkavy-Friedman; Adam Jonathan Savitz; Dolores Malaspina; Jeffrey Paul Kahn
Journal:  Psychiatry Res       Date:  2012-03-13       Impact factor: 3.222

9.  S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin Resistance.

Authors:  Johann Steiner; Aye Mu Myint; Kolja Schiltz; Sabine Westphal; Hans-Gert Bernstein; Martin Walter; Matthias L Schroeter; Markus J Schwarz; Bernhard Bogerts
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-06-10

10.  Impaired hippocampal-dependent memory and reduced parvalbumin-positive interneurons in a ketamine mouse model of schizophrenia.

Authors:  Ming Teng Koh; Yi Shao; Andrew Sherwood; Dani R Smith
Journal:  Schizophr Res       Date:  2016-01-19       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.